Impact of non-steroidal anti-inflammatory drugs on cardiovascular risk: Is it the same in osteoarthritis and rheumatoid arthritis?
出版年份 2016 全文链接
标题
Impact of non-steroidal anti-inflammatory drugs on cardiovascular risk: Is it the same in osteoarthritis and rheumatoid arthritis?
作者
关键词
-
出版物
Modern Rheumatology
Volume 27, Issue 4, Pages 559-569
出版商
Informa UK Limited
发表日期
2016-09-23
DOI
10.1080/14397595.2016.1232332
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Drugs and cardiovascular risk in inflammatory arthritis: another case of glucocorticoid-bashing?
- (2015) Maarten Boers ANNALS OF THE RHEUMATIC DISEASES
- The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis
- (2015) Camille Roubille et al. ANNALS OF THE RHEUMATIC DISEASES
- Long-Term Frequent Use of Non-Steroidal Anti-Inflammatory Drugs Might Protect Patients with Ankylosing Spondylitis from Cardiovascular Diseases: A Nationwide Case-Control Study
- (2015) Wen-Chan Tsai et al. PLoS One
- Increased Risk of Chronic Kidney Disease in Rheumatoid Arthritis Associated with Cardiovascular Complications – A National Population-Based Cohort Study
- (2015) Hsien-Yi Chiu et al. PLoS One
- Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation
- (2014) Y Chen et al. HEALTH TECHNOLOGY ASSESSMENT
- Risk of nonfatal acute myocardial infarction associated with non-steroidal antiinflammatory drugs, non-narcotic analgesics and other drugs used in osteoarthritis: a nested case-control study
- (2014) Francisco J. de Abajo et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Inadequate pain relief and large functional loss among patients with knee osteoarthritis: evidence from a prospective multinational longitudinal study of osteoarthritis real-world therapies
- (2014) Philip G. Conaghan et al. RHEUMATOLOGY
- Depression and Cardiovascular Disease: An Update on How Course of Illness May Influence Risk
- (2014) Jess G. Fiedorowicz Current Psychiatry Reports
- Non-steroidal anti-inflammatory drugs and risk of cardiovascular disease in patients with rheumatoid arthritis: a nationwide cohort study
- (2013) Jesper Lindhardsen et al. ANNALS OF THE RHEUMATIC DISEASES
- Cardiovascular risk in rheumatoid arthritis: How to lower the risk?
- (2013) D.F. van Breukelen-van der Stoep et al. ATHEROSCLEROSIS
- Advice from Professional Societies: Appropriate Use of NSAIDs
- (2013) Alexa Simon Meara et al. PAIN MEDICINE
- Myocardial infarction and individual nonsteroidal anti-inflammatory drugs meta-analysis of observational studies
- (2013) Cristina Varas-Lorenzo et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Cause-Specific Cardiovascular Risk Associated with Nonsteroidal Anti-Inflammatory Drugs among Myocardial Infarction Patients - A Nationwide Study
- (2013) Anne-Marie Schjerning Olsen et al. PLoS One
- Glucocorticoid Dose Thresholds Associated With All-Cause and Cardiovascular Mortality in Rheumatoid Arthritis
- (2013) Inmaculada del Rincón et al. Arthritis & Rheumatology
- Population-Based Incidence and Prevalence of Systemic Lupus Erythematosus: The Michigan Lupus Epidemiology and Surveillance Program
- (2013) Emily C. Somers et al. Arthritis & Rheumatology
- Comparative effects of non-steroidal anti-inflammatory drugs (NSAIDs) on blood pressure in patients with hypertension
- (2012) Hisham Aljadhey et al. BMC Cardiovascular Disorders
- Risk of new acute myocardial infarction hospitalization associated with use of oral and parenteral non-steroidal anti-inflammation drugs (NSAIDs): a case-crossover study of Taiwan's National Health Insurance claims database and review of current evidence
- (2012) Wen-Yi Shau et al. BMC Cardiovascular Disorders
- Cardiovascular safety of lumiracoxib: a meta-analysis of randomised controlled trials in patients with osteoarthritis
- (2012) Isla S. Mackenzie et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Harmful Effects of NSAIDs among Patients with Hypertension and Coronary Artery Disease
- (2011) Anthony A. Bavry et al. AMERICAN JOURNAL OF MEDICINE
- Dose Response Between Physical Activity and Risk of Coronary Heart Disease
- (2011) Jacob Sattelmair et al. CIRCULATION
- A 13-week, multicenter, randomized, double-blind study of lumiracoxib in hip osteoarthritis
- (2011) Thomas J. Schnitzer et al. CLINICAL RHEUMATOLOGY
- Impact of non-steroidal anti-inflammatory drugs (NSAIDs) on cardiovascular outcomes in patients with stable atherothrombosis or multiple risk factors
- (2011) Olivier Barthélémy et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Cardiovascular Risk with Non-Steroidal Anti-Inflammatory Drugs: Systematic Review of Population-Based Controlled Observational Studies
- (2011) Patricia McGettigan et al. PLOS MEDICINE
- Use of Non-Steroidal Antiinflammatory Drugs and Type-Specific Risk of Acute Coronary Syndrome
- (2010) Héctor Bueno et al. AMERICAN JOURNAL OF CARDIOLOGY
- Excess risk of hospital admission for cardiovascular disease within the first 7 years from onset of inflammatory polyarthritis
- (2010) J. Franklin et al. ANNALS OF THE RHEUMATIC DISEASES
- Use of non-steroidal anti-inflammatory drugs and risk of incident myocardial infarction and heart failure, and all-cause mortality in the Australian veteran community
- (2010) Arduino A. Mangoni et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Should Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) be Prescribed to the Older Adult?
- (2010) Robert L. Barkin et al. DRUGS & AGING
- Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial
- (2010) Francis KL Chan et al. LANCET
- EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis
- (2009) M J L Peters et al. ANNALS OF THE RHEUMATIC DISEASES
- Increased Mortality and Cardiovascular Morbidity Associated With Use of Nonsteroidal Anti-inflammatory Drugs in Chronic Heart Failure
- (2009) Gunnar H. Gislason et al. ARCHIVES OF INTERNAL MEDICINE
- Atherosclerosis in Rheumatoid Arthritis Versus Diabetes
- (2009) Kimon S. Stamatelopoulos et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Non-aspirin NSAIDs, cyclooxygenase-2 inhibitors and risk for cardiovascular events-stroke, acute myocardial infarction, and death from coronary heart disease
- (2009) Christianne L. Roumie et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- The use of selective cyclooxygenase-2 inhibitors and the risk of acute myocardial infarction in Saskatchewan, Canada
- (2009) Cristina Varas-Lorenzo et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRE Investigation
- (2008) V P van Halm et al. ANNALS OF THE RHEUMATIC DISEASES
- Non-steroidal anti-inflammatory drug use does not appear to be associated with increased cardiovascular mortality in patients with inflammatory polyarthritis: results from a primary care based inception cohort of patients
- (2008) N J Goodson et al. ANNALS OF THE RHEUMATIC DISEASES
- The balance between severe cardiovascular and gastrointestinal events among users of selective and non-selective non-steroidal anti-inflammatory drugs
- (2008) M W van der Linden et al. ANNALS OF THE RHEUMATIC DISEASES
- Cardiovascular, rheumatologic, and pharmacologic predictors of stroke in patients with rheumatoid arthritis: A nested, case-control study
- (2008) Zurab Nadareishvili et al. ARTHRITIS AND RHEUMATISM
- Subgroup analyses to determine cardiovascular risk associated with nonsteroidal antiinflammatory drugs and coxibs in specific patient groups
- (2008) Daniel H. Solomon et al. ARTHRITIS AND RHEUMATISM
- What is the harm-benefit ratio of Cox-2 inhibitors?
- (2008) T P van Staa et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Effect of inflammation on kidney function and pharmacokinetics of COX-2 selective nonsteroidal anti-inflammatory drugs rofecoxib and meloxicam
- (2008) Sam Harirforoosh et al. JOURNAL OF APPLIED TOXICOLOGY
- COX-2 selectivity alone does not define the cardiovascular risks associated with non-steroidal anti-inflammatory drugs
- (2008) Timothy D Warner et al. LANCET
- Risk of ischaemic cardiovascular events from selective cyclooxygenase-2 inhibitors in osteoarthritis
- (2008) Marianne Cunnington et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Onset of acute myocardial infarction after use of non-steroidal anti-inflammatory drugs
- (2008) Tarek A. Hammad et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now